» Articles » PMID: 21983869

Impairment of Non-muscle Myosin IIA in Human CD4+ T Cells Contributes to Functional Deficits in the Elderly

Overview
Date 2011 Oct 11
PMID 21983869
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Physiological aging imposes significant alterations in the repertoire of T cells and all associated functions. Although several studies have reported defects upon antigen-induced activation of T cells during aging, the molecular mechanisms that control T-cell receptor (TCR) downmodulation remain to be fully defined. While previous studies have assessed the role of F-actin in regulating activation-induced TCR internalization, few have delineated the roles of motor proteins, such as non-muscle myosin IIA (NMMIIA). In this study, we describe a series of experiments supporting the hypothesis that effective TCR downmodulation requires not only efficient reorganization of the actin cytoskeleton, but also functional NMMIIA. For the first time, we show that CD4(+) T cells from elderly human donors have dysfunctional NMMIIA that contributes to delaying activation-induced TCR internalization and impairing calcium mobilization. Additionally, our results demonstrate that chemical inhibition of NMMIIA in CD4(+) T cells from young donors also results in complete abrogation of TCR internalization, strongly supporting the fundamental role of NMMIIA in modulating this event. Recent observations that the generation of an efficient T-cell response requires migration prompted us to investigate whether NMMIIA also plays a regulatory role in CD4(+) T-cell migration. We show that chemical inhibition of NMMIIA downmodulates chemotactic migration in CD4(+) T cells from both young and elderly donors. Together, these data demonstrate a significant contribution of dysfunctional NMMIIA to TCR-mediated functional defects during aging.

Citing Articles

DRAK2 regulates myosin light chain phosphorylation in T cells.

Wilander B, Harris T, Mandarano A, Guy C, Prater M, Pruett-Miller S J Cell Sci. 2024; 137(22).

PMID: 39421891 PMC: 11607690. DOI: 10.1242/jcs.261813.


Rejuvenation of leukocyte trafficking in aged mice through PEPITEM intervention.

Hopkin S, Nathan P, Pezhman L, Begum J, Manning J, Quinn L NPJ Aging. 2024; 10(1):33.

PMID: 39025913 PMC: 11258258. DOI: 10.1038/s41514-024-00160-6.


Mechanotransduction in Skin Inflammation.

Shutova M, Boehncke W Cells. 2022; 11(13).

PMID: 35805110 PMC: 9265324. DOI: 10.3390/cells11132026.


Elimination of N-glycosylation by site mutation further prolongs the half-life of IFN-α/Fc fusion proteins expressed in Pichia pastoris.

Jia H, Guo Y, Song X, Shao C, Wu J, Ma J Microb Cell Fact. 2016; 15(1):209.

PMID: 27927205 PMC: 5142404. DOI: 10.1186/s12934-016-0601-9.


Non-muscle myosin II in disease: mechanisms and therapeutic opportunities.

Newell-Litwa K, Horwitz R, Lamers M Dis Model Mech. 2015; 8(12):1495-515.

PMID: 26542704 PMC: 4728321. DOI: 10.1242/dmm.022103.


References
1.
Gautam N, Das S, Mahapatra S, Chakraborty S, Kundu P, Roy S . Age associated oxidative damage in lymphocytes. Oxid Med Cell Longev. 2010; 3(4):275-82. PMC: 2952088. DOI: 10.4161/oxim.3.4.12860. View

2.
Choudhuri K, Dustin M . Signaling microdomains in T cells. FEBS Lett. 2010; 584(24):4823-31. PMC: 3870024. DOI: 10.1016/j.febslet.2010.10.015. View

3.
Rajagopal D, Bal V, Mayor S, George A, Rath S . A role for the Hsp90 molecular chaperone family in antigen presentation to T lymphocytes via major histocompatibility complex class II molecules. Eur J Immunol. 2006; 36(4):828-41. PMC: 7616457. DOI: 10.1002/eji.200535326. View

4.
Crevecoeur J, Merville M, Piette J, Gloire G . Geldanamycin inhibits tyrosine phosphorylation-dependent NF-kappaB activation. Biochem Pharmacol. 2008; 75(11):2183-91. DOI: 10.1016/j.bcp.2008.03.009. View

5.
Garcia G, Miller R . Age-dependent defects in TCR-triggered cytoskeletal rearrangement in CD4+ T cells. J Immunol. 2002; 169(9):5021-7. DOI: 10.4049/jimmunol.169.9.5021. View